47 results
8-K
EX-99.1
EQ
Equillium Inc
4 Jun 24
Other Events
8:00am
drugs are all JAK inhibitors There remains a chronic need for a safer chronic treatment Dermatologists indicate safety concerns are the primary barriers … *) and Swelling face (related*) 5) Fatigue (related*) Week 10 Week 12 Week 2 Week 1 Week 12 History of chronic kidney disease and was diagnosed with IgA
8-K
EX-99.1
EQ
Equillium Inc
16 Oct 23
Regulation FD Disclosure
8:05am
inhibitors See full prescribing information for complete boxed warning. There remains a chronic need, * Increased risk of serious bacterial, fungal … , viral and for my AA patients” opportunistic infections leading to hospitalization or death, without a safe chronic treatment including tuberculosis (TB
425
e6risc trh7e
28 Sep 22
Business combination disclosure
6:01am
425
aaqysgivh3c 3zq
27 Sep 22
Business combination disclosure
9:30am
8-K
EX-99.1
m50 h64f79co
27 Sep 22
Other Events
9:28am
8-K
EX-99.1
40d4 31ksbh2pmtdo
4 Mar 22
Equillium Announces Initiation of the Phase 3 EQUATOR Study of Itolizumab in First-line Acute Graft-Versus-Host Disease
2:00pm
8-K
lan30qf
2 Mar 22
Equillium Announces Appointment of Barbara Troupin to Board of Directors
9:00am
8-K
EX-99.1
3hu uvdci8
2 Mar 22
Equillium Announces Appointment of Barbara Troupin to Board of Directors
9:00am
8-K
EX-99.1
dfoscr kurae
30 Mar 21
Equillium Announces Favorable Data From Phase 1b EQUALISE Study in Systemic Lupus Erythematosus Patients
4:52pm
8-K
EX-99.1
udwl7v3u 8b22l1
9 Mar 21
Regulation FD Disclosure
7:00am